Studies showed that elevated gal-3 level is a poor prognostic factor in different solid tumors as prostate cancer [6], melanoma [7] and haematological disorders as nonhodgkin lymphoma (NHL) [8], multiple myeloma [9] and acute myeloid leukemia patients [10]. The gene discussed is LGALS3; the disease is acute myeloid leukemia.